{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:16:53Z","timestamp":1790241413122,"version":"4.1.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is a high therapeutic need in acantholytic and blistering genodermatoses. Cutaneous inflammation is a reasonable therapeutic target, although the patterns are not yet fully elucidated. Here we investigated by immunohistochemistry whether interleukin (IL)-17A is expressed in the inflammatory infiltrate in 34 patients with Hailey\u2013Hailey disease, Darier disease, and junctional and dystrophic epidermolysis bullosa. There was a 5\u20137-fold increase in the number of IL-17A-positive cells in all patients\u2019 samples as compared with normal skin. IL-17A cells were present in epidermal acantholytic areas and dermal inflammatory infiltrates in Hailey\u2013Hailey and Darier disease. In epidermolysis bullosa samples, positive cells were present at the dermoepidermal junction zone. The IL-17A inflammatory pattern was validated by observing upregulation of downstream genes\/proteins, S100A7, S100A8 and S100A9 (S100 calcium-binding proteins). These results suggest that IL-17A contributes to skin inflammation and could be a therapeutic target during inflammatory flares in these disorders.<\/jats:p>","DOI":"10.1093\/ced\/llad012","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T03:30:44Z","timestamp":1673494244000},"page":"518-523","source":"Crossref","is-referenced-by-count":31,"title":["Interleukin-17A immune pattern across genetic acantholytic and blistering disorders"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-3140","authenticated-orcid":false,"given":"Asal","family":"Haghighi Javid","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical Center \u2013 University of Freiburg, Faculty of Medicine , Freiburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8825-6806","authenticated-orcid":false,"given":"Donglin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Center \u2013 University of Freiburg, Faculty of Medicine , Freiburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5183-1328","authenticated-orcid":false,"given":"Kristin","family":"Technau-Hafsi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Center \u2013 University of Freiburg, Faculty of Medicine , Freiburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6066-507X","authenticated-orcid":false,"given":"Cristina","family":"Has","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Center \u2013 University of Freiburg, Faculty of Medicine , Freiburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"2023100416443468900_llad012-B1","doi-asserted-by":"crossref","first-page":"e1528","DOI":"10.1097\/MD.0000000000001528","article-title":"Proinflammatory\u00a0cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa","volume":"94","author":"Annicchiarico","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2023100416443468900_llad012-B2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/1346-8138.16178","article-title":"Two cases of Hailey-Hailey disease effectively treated with apremilast and a review of reported cases","volume":"48","author":"Yoto","year":"2021","journal-title":"J Dermatol"},{"key":"2023100416443468900_llad012-B3","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jid.2022.01.020","article-title":"Predominance of Staphylococcus correlates with wound burden and disease activity in dystrophic epidermolysis bullosa: a prospective case\u2013control study","volume":"142","author":"Reimer-Taschenbrecker","year":"2022","journal-title":"J Invest Dermatol"},{"key":"2023100416443468900_llad012-B4","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/jdv.12025","article-title":"Bacteriological aspects of Darier\u2019s disease","volume":"27","author":"Dodiuk-Gad","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023100416443468900_llad012-B5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2023100416443468900_llad012-B6","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg9302","article-title":"Interleukin-17 governs hypoxic adaptation of injured epithelium","volume":"377","author":"Konieczny","year":"2022","journal-title":"Science"},{"key":"2023100416443468900_llad012-B7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjd.16897","article-title":"Epidermolysis bullosa simplex generalized severe induces a T helper 17 response and is improved by apremilast treatment","volume":"180","author":"Castela","year":"2019","journal-title":"Br J Dermatol"},{"key":"2023100416443468900_llad012-B8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jdcr.2022.09.014","article-title":"Adalimumab therapy used successfully for recalcitrant Hailey\u2013Hailey disease","volume":"29","author":"Chen","year":"2022","journal-title":"JAAD Case Rep"},{"key":"2023100416443468900_llad012-B9","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.884359","article-title":"Case report: difference in outcomes between two cases of Hailey\u2013Hailey disease treated with apremilast","volume":"13","author":"Yamaga","year":"2022","journal-title":"Front Genet"},{"key":"2023100416443468900_llad012-B10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jamadermatol.2022.1021","article-title":"Response of Darier disease following treatment with baricitinib","volume":"158","author":"Busto Leis","year":"2022","journal-title":"JAMA Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad012\/49287508\/llad012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/5\/518\/51854781\/llad012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/5\/518\/51854781\/llad012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T12:45:01Z","timestamp":1696423501000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/5\/518\/6985906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2023,4,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad012","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,1,12]]}}}